Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results

Go back to Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
(NASDAQ: LRMR) Delayed: 4.25 +0.19 (4.68%)
Previous Close $4.06    52 Week High
Open $4.19    52 Week Low
Day High $4.34    P/E N/A 
Day Low $4.17    EPS
Volume 1,232,261       

(NASDAQ: LRMR) Delayed: 4.25 +0.19 (4.68%)
Previous Close $4.06    52 Week High
Open $4.19    52 Week Low
Day High $4.34    P/E N/A 
Day Low $4.17    EPS
Volume 1,232,261